https://www.marketscreener.com/quote/stock/ULTIMOVACS-ASA-59297686/news/Ultimovacs-ASA-Receives-FDA-Orphan-Drug-Designation-for-the-Uv1-Cancer-Vaccine-for-Treatment-of-Meso-45024215/?utm_source=telegram&utm_medium=social&utm_campaign=share